跳至主要内容
临床试验/NCT03087877
NCT03087877已完成不适用

Evaluation of the Dexcom G6 Continuous Glucose Monitoring System With a Non-Interferent Sensor

DexCom, Inc.4 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年2月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
DexCom, Inc.
入组人数
70
试验地点
4
主要终点
Interference Effect for the G6 CGM

研究概览

简要总结

The objective of the study is to demonstrate effectiveness of the G6 sensor membrane, in preventing acetaminophen's interference effect on glucose sensing.

详细描述

The interference effect of the sensor will be evaluated by comparing the bias in the glucose values exhibited from the G6 CGM system after administration of acetaminophen. Bias will be evaluated by comparing CGM values to a laboratory referenceusing venous sample measurements.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

盲法说明

The system will be blinded to the user, i.e. no glucose values will be displayed to the subject during the study duration.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 18 or older
  • Diagnosis of diabetes

排除标准

  • Pregnancy
  • Known gastroparesis
  • Abnormal liver function

研究组 & 干预措施

CGM Users

Other

Prospective, non-randomized, single-arm. Continuous Glucose Monitoring. Acetaminophen challenge is the intervention.

干预措施: Acetaminophen Challenge (G6 CGM) (Device)

结局指标

主要结局

Interference Effect for the G6 CGM

时间窗: 6 hrs post dose

Bias of sensor to reference measurement pre and post acetaminophen administration

次要结局

  • Mean of sensor minus YSI values (bias) for various time periods(6 hrs post dose)
  • Duration of interference effect for the G6 CGM(6 hrs post dose)

研究者

发起方
DexCom, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验